Dr. Reddy's Laboratories Limited has grown revenue 15% a year over three years and 13% a year over five, with earnings per share compounding at −82%. Revenue growth, 3-year annual rate: +15% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Earnings per share, 3-year rate: −82%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 10, FY2016 to FY2025, as filed.

RDYDr. Reddy's Laboratories Limited

HealthcareUSD

$12.22

$11.4052 weeks$15.25

Is it growing?

Is RDY growing?

Dr. Reddy's Laboratories Limited has grown revenue 15% a year over three years and 13% a year over five, with earnings per share compounding at −82%.

+15%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +15% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −82%
Earnings per share, 3-year rate · revenue +15% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed